Worldwide TCV Vaccines Industry to 2030 - Featuring GlaxoSmithKline, Sanofi and Bharat Biotech Among Others
TCV Vaccines Market
Dublin, April 18, 2022 (GLOBE NEWSWIRE) -- The "TCV Vaccines Market, by Vaccine Brand, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
Typbar TCV vaccine is a typhoid vaccine recommended for the prevention of typhoid fever. Typbar TCV vaccine works by causing the body to produce its own protection (antibodies) against the bacteria. This vaccine is generally recommended for individuals who are traveling to areas where typhoid fever is common.
Ongoing Typbar-TCV studies will provide important data of great value to typhoid-fever-endemic regions, and for incorporation of the vaccine into routine immunization programs in endemic regions such as Asia, Latin America and others to control drug-resistant typhoid fever and the spread of antimicrobial resistance globally. World Health Organization recommends the introduction of typhoid conjugate vaccine (TCV) for infants and children over six months of age in typhoid-endemic countries.
This new policy help and ensure access to typhoid vaccination in communities most impacted by the disease, which is responsible for nearly 12 million infections and between 128,000 and 161,000 deaths a year. Typhoid disproportionally impacts young children and marginalized populations in much of Asia Pacific, Sub-Saharan Africa, and parts of Latin America and the Middle East that often have outdated, inadequate, or unsafe water and sanitation systems. With supportive global and financial policies in place, typhoid vaccines, in addition to water, sanitation, and hygiene interventions, can reach those who need them most and reduce the burden of typhoid fever.
Market Dynamics
Increasing prevalence of typhoid, increasing government initiatives promoting and advancing the development of innovative products, increasing antibiotic resistance and adoption of inorganic growth strategies such as collaboration and agreement, in order to expand their product portfolio and strengthen their presence in the market. These are the major factors expected to drive the growth of global TCV vaccines market over the forecast period.
Key features of the study:
This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global TCV vaccines market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include GlaxoSmithKline PLC, Sanofi SA, Bharat Biotech, PT BIO FARMA, and PaxVax, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market
Key Topics Covered:
1. Research Objectives and Assumptions
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Vaccine Brand
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
PEST Analysis
Regulatory Scenario
Market Trends
Key Highlights
Reimbursement Scenario
Mergers & Acquisitions
4. Global TCV Vaccines Market - Impact of Coronavirus (COVID-19) Pandemic
Economic Impact
Government Initiatives
5. Global TCV Vaccines Market, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Ty21a (Vivotif)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
ViCPS (Typhim Vi)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Vi-TT (Peda-typhTM)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
Typbar TCV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
6. Global TCV Vaccines Market, By Distribution Channel, 2017 - 2030, (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2030 (%)
Y-o-Y Growth Analysis, 2018 - 2030
Segment Trends
Public
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
UNICEF
Tender (Govt.)
Private
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2030, (US$ Mn)
7. Global TCV Vaccines Market, By Region, 2017 - 2030, (US$ Mn)
Introduction
Market Share Analysis, By Region, 2022 and 2030 (%)
Y-o-Y Growth Analysis, For Regions, 2018-2030
North America
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
U.S.
Canada
Latin America
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Country, 2017 - 2030, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Vaccine Brand, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Distribution Channel, 2017 - 2030, (US$ Mn)
Market Size and Forecast, By Region/Country, 2017 - 2030, (US$ Mn)
South Africa
Central Africa
North Africa
8. Competitive Landscape
Heat Map Analysis
Market Share Analysis
GlaxoSmithKline PLC
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Sanofi SA
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Bharat Biotech
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
PT BIO FARMA
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
PaxVax, Inc.
Company Overview
Product Portfolio
Financial Overview
Key Highlights
Market Strategies
Analyst Views
9. Section
For more information about this report visit https://www.researchandmarkets.com/r/1koq83
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900